Use of pharmacogenetic methodologies in the pharmacokinetic evaluation of medicinal products

Current effective version

PDF iconAdopted guideline

Reference numberEMA/CHMP/37646/2009
Published02/02/2012
Effective from01/08/2012
KeywordsPharmacogenetics, pharmacokinetics, clinical development
DescriptionThis document addresses the influence of pharmacogenetics on drug pharmacokinetics, encompassing considerations and requirements for the design and conduct of investigations during drug development.


Document history

First version

Current version

PDF iconAdopted guideline


PDF iconDraft guideline


PDF iconConcept paper

In operation: 01/08/2012–present


Published: 06/05/2010


Published: 23/04/2009

Superseded document


PDF iconReflection paper


PDF iconOverview of comments


PDF iconDraft reflection paper

Published: 25/05/2007


Published: 24/05/2007


Published: 01/07/2006


Related content


How useful was this page?

Add your rating